AI assistant
ANI PHARMACEUTICALS INC — Director's Dealing 2026
Feb 17, 2026
31676_dirs_2026-02-17_c8e87819-c8e7-488e-939f-33aa2f343a4d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2026-02-12
Reporting Person: Cook Meredith (SR. VP, GENERAL COUNSEL & SEC.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-12 | Common Stock | F | 1534 | $76.70 | Disposed | 69829 | Direct |
| 2026-02-13 | Common Stock | S | 500 | $76.80 | Disposed | 69329 | Direct |
| 2026-02-14 | Common Stock | F | 1779 | $77.36 | Disposed | 67550 | Direct |
Footnotes
F1: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,243 shares of restricted stock, the grant of which was previously reported on February 18, 2025.
F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025.
F3: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,691 shares of restricted stock, the grant of which was previously reported on February 16, 2024.